Skip to main content
. Author manuscript; available in PMC: 2017 Nov 21.
Published in final edited form as: J Am Coll Cardiol. 2015 Jan 6;65(1):1–11. doi: 10.1016/j.jacc.2014.09.078

Table 3.

Cost-Effectiveness Analysis: Matched Analytic Population

Δ
CABG
PCI
Life
Years or
QALY
Gained
with
CABG
ICER %
CABG
Dominated
% CABG
Dominant
%
<$30,000
/LYG
%
<$50,000
/LYG
%
<$100,000
/LYG
Life years from 2004 through 2008 $8,079 0.2674 $30,217 0 0 45.0 100.0 100.0
Lifetime (3% discount) $12,157 0.3172 $38,330 0 0 0 100.0 100.0
Quality-adjusted lifetime (3% discount) $12,157 0.3947 $30,803 0 0 21.0 100.0 100.0

Abbreviations as in Tables 1, 2, and 4.